N@N

Alcatel-Lucent, Cisco Systems Inc., LM Ericsson Telephone Co., InterMune Inc. and Roche Holdings Ltd.

^{Published on 2010-11-05 10:00:40 - Market Wire}
 

CHICAGO--([ BUSINESS WIRE ])--Zacks.com Analyst Blog features: Alcatel-Lucent (NYSE: [ ALU ]), Cisco Systems Inc. (Nasdaq: [ CSCO ]), LM Ericsson Telephone Co. (Nasdaq: [ ERIC ]), InterMune Inc. (Nasdaq: [ ITMN ]) and Roche Holdings Ltd. (OTC: [ RHHBY ]).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: [ http://at.zacks.com/?id=4579 ]

Here are highlights from Thursdaya™s Analyst Blog:

Alcatel-Lucent Returns to Profit

Alcatel-Lucent (NYSE: [ ALU ]) reported net earnings from continuing operations of a'0.01 per share or 2 cents per share in the third quarter of 2010, ahead of the Zacks Consensus Estimate of break-even. The company had reported net loss per share of a'0.08 or 12 cents in the third quarter of 2009.

During the quarter, the company was successful in converting its top-line growth into profit and cash flow through its operating efficiency and focus on reducing organizational complexity.

Total Revenue

Strong customer base and continued market share gain of Alcatel-Lucenta™s next generation products increased total revenue by 10.5% year over year to a'4.1 billion. In terms of dollar, revenue in the quarter was approximately $5.25 billion, above the Zacks Consensus Estimate of $5.07 billion. Excluding the effect of currency fluctuations, revenue was up 2.9%.

Geographically, North America experienced revenue growth of 21.6% and Asia-Pacific witnessed a growth of 18.3%. Though revenue in Europe declined by 0.2%, it was up by mid single digit points in Eastern Europe. Rest of the World revenue was down by 1.2%. The company saw a strong growth in India and Russia and also witnessed a recovery in China.

Segmental Performance

Networks revenue increased by 10.2% year over year to a'2.5 billion, whereas Application revenue increased by 5.5% to a'499 million and Services revenue increased by 9.1% to a'948 million.

In Networks segment, though the revenue from IP division increased by 29.3% and Wireless division by 24.2%, this was offset by a 7.8% decline in revenue from Optics division and a 2.0% decrease in Wireline division. The segmentsa™ adjusted operating margin was 1.3% compared with -1.2% in the third quarter of 2009.

Within the Application segment, Network Application revenue increased 3.5% while Enterprise Application showed a continued sign of recovery with revenue increasing by 7.2%. The segmenta™s operating margin was 3% compared with break-even adjusted operating income in the prior-year period, primarily driven by strong contributions from Enterprise business.

Within the Service segment, managed and outsourcing solutions revenue increased at a double digit rate, led by new contracts and existing project development, mainly in EMEA and Asia-Pacific regions. Network Build and Implementation business also witnessed a double digit growth, led by growth in EMEA and the Americas. The segmenta™s operating margin was 3.0% versus 4.4% in the prior-year period.

Income & Expenses

Adjusted operating income for the quarter was a'61 million (1.5% of revenue). The positive product/geographic mix and Alcatela™s initiatives on fixed cost operations resulted in 40 basis points year over year increase in gross margin to 33.8%.

Moreover, operating expenses declined by 0.7% on a constant currency basis, but increased by 5.9% on reported basis. Sequentially, operating expenses declined by 0.2% on a constant currency basis and by 2.4% on a reported basis resulting from lower SG&A expenses.

Balance Sheet & Cash Flows

At the end of the quarter, Alcatel-Lucent had net debt of a'190 million compared with net cash of a'107 million at the end of the second quarter. The companya™s positive operating cash flow of a'193 million was more than offset by cash spending of a'73 million for restructuring, a'56 million in contribution to pensions and OPEB and a'184 million of capital expenditure.

Outlook

Alcatel reiterated its outlook for 2010, and expects a nominal growth (i.e. 0% to 5%) for the telecommunications equipment and related services market. For 2010, Alcatel-Lucent expects adjusted operating margin to be in the range of low to mid single-digit (i.e. 1% to 5%).

We are encouraged by the continued progress in cost management highlighted by the year-over-year increase of gross margin and continued decrease in operating expenses. With strengthening demand in some segments and geographical areas, we expect the company to deliver strong results in top line and operating income levels ahead.

Based in Paris, Alcatel-Lucent is a diversified global manufacturer of telecom equipment with over 77,000 employees in 130 countries worldwide. Apart from being the worlda™s leading supplier of digital subscriber line (DSL) equipment, Alcatel-Lucent is among the leaders in telephone switching equipment, optical and data networking gear, mobile infrastructure, and communications software.

The company has also been a big player in mobile handsets, fiber optic cable, and Internet routers. Major competitors of Alcatel-Lucent are Cisco Systems Inc. (Nasdaq: [ CSCO ]) and LM Ericsson Telephone Co. (Nasdaq: [ ERIC ]).

We currently maintain our Neutral rating for the long term on Alcatel-Lucent, with a Zacks #2 Rank (short-term Buy recommendation) over the next one-to-three months.

Wider Loss at InterMune

InterMune Inc. (Nasdaq: [ ITMN ]) posted third-quarter loss per share of 44 cents, wider than the year-ago loss per share of 19 cents, but narrower than the Zacks Consensus Estimate of a loss per share of 50 cents. Decreased revenues resulted in the earnings shortfall.

Quarterly Details

Third quarter total revenue of $5.7 million was slightly below the Zacks Consensus Estimate of $6 million. However, revenues plummeted 378.9% from the year-ago quarter revenue of $27.3 million. The sharp decline was mainly due to the inclusion of a $20.0 million milestone payment received during the third quarter of 2009. The payment was received from Roche Holdings Ltd. (OTC: [ RHHBY ]) for the initiation of a phase IIb trial of danoprevir in patients chronically infected with the hepatitis C virus (HCV).

During the reported quarter, research and development (R&D) expenses declined 24% to $15.6 million. The decrease was the result of the completion of CAPACITY trials of pirfenidone in 2009 and the timing of danoprevir clinical trials.

General and administrative (G&A) expenses increased 10% to $10.9 million. The increase was primarily due to commercialization costs associated with the potential launch of pirfenidone (Esbriet; for idiopathic pulmonary fibrosis).

Fiscal 2010 Outlook

For fiscal 2010, InterMune expects R&D expenses to lie between $65 million and $70 million, down from the previous guidance range of $80 million to $90 million. The company tightened its guidance for G&A expenses. The expenses are anticipated to range from $45 million to $50 million as opposed to the earlier range of $40 million to $50 million.

InterMune did not come up with a revenue outlook for 2010 as the accounting treatment of the deal through which InterMune sold the global development and commercialization rights for danoprevir to Roche, in October, has not been finalized.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: [ http://at.zacks.com/?id=5514 ].

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: [ http://at.zacks.com/?id=5516 ]

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at [ http://at.zacks.com/?id=4580 ].

Visit [ http://www.zacks.com/performance ] for information about the performance numbers displayed in this press release.

Follow us on Twitter: [ http://twitter.com/zacksresearch ]

Join us on Facebook: [ http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts ]

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.